In the relentless pursuit of novel therapeutic agents, particularly in oncology, the identification and utilization of specialized chemical intermediates are paramount. One such compound gaining significant attention is 2,4-Difluoro-5-Nitrobenzonitrile, identifiable by its CAS number 67152-20-9. This molecule, supplied by NINGBO INNO PHARMCHEM CO.,LTD., serves as a critical building block in the synthesis of potent and selective tankyrase inhibitors. Tankyrase inhibitors are a class of compounds that show immense promise in the fight against tumorigenesis, a process fundamental to cancer development.

The unique chemical structure of 2,4-Difluoro-5-Nitrobenzonitrile, featuring fluorine atoms and a nitro group attached to a benzonitrile core, endows it with specific reactivity and properties highly sought after in advanced organic synthesis. These characteristics are instrumental in developing drugs that precisely target cancer cells and pathways. Researchers often look for reliable 2,4-Difluoro-5-Nitrobenzonitrile suppliers to ensure the quality and consistency required for drug development programs. The compound’s role in creating these targeted therapies underscores its importance in modern medicine and highlights the demand for high-quality CAS 67152-20-9 pharmaceutical applications.

As a leading pharmaceutical intermediate manufacturer in China, NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing access to such vital compounds. Our dedication to quality ensures that each batch of 2,4-Difluoro-5-Nitrobenzonitrile meets stringent purity standards, making it ideal for sensitive research and large-scale production. The ability to procure essential tankyrase inhibitor synthesis intermediates like this is crucial for accelerating the development of new cancer treatments. By understanding the significance of these fluorinated benzonitrile derivatives, we empower researchers and pharmaceutical companies to push the boundaries of medical innovation.